aluates Reports

$ 0.0

Automative

Global Lymphedema Diagnostics Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-32W5815

Global Lymphedema Diagnostics Market Insights Forecast to 2028

BUY CHAPTERS

Global Lymphedema Diagnostics Market Insights, Forecast to 2030

Code: QYRE-Auto-32W5815

Report

December 2024

Pages:110

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GE Healthcare

Siemens Healthineers (A Subsidiary of Siemens Group)

Philips

Canon Inc

Shimadzu Corporation

Stryker Corporation

FLUOPTICS

United Imaging Healthcare Co., Ltd.

Hitachi

Esaote SpA

Neusoft Corporation

Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.)

Mitaka USA, Inc

Curadel, LLC

ImpediMed

Lymphedema Diagnostics Market Size

The global Lymphedema Diagnostics market is projected to grow from US$ 28 million in 2024 to US$ 39 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period.

Lymphedema Diagnostics Market

Lymphedema, also known as lymphoedema and lymphatic edema, is a condition of localized swelling caused by a compromised lymphatic system. The lymphatic system functions as a critical portion of the body's immune system and returns interstitial fluid to the bloodstream. Lymphedema is most frequently a complication of cancer treatment or parasitic infections, but it can also be seen in a number of genetic disorders. Though incurable and progressive, a number of treatments may improve symptoms. Tissues with lymphedema are at high risk of infection because the lymphatic system has been compromised.

Market Analysis and Insights: Global Lymphedema Diagnostics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Lymphedema Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Lymphedema Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Lymphedema Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lymphedema Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Lymphedema Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Lymphedema Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Lymphedema Diagnostics Market Report

Report Metric	Details
Report Name	Lymphedema Diagnostics Market
Accounted market size in 2024	US$ 28 in million
Forecasted market size in 2030	US$ 39 million
CAGR	5.4
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Lymphoscintigraphy Magnetic Resonance Imaging Ultrasound Imaging Computed Tomography X-Ray Lymphography Bioimpedance Analysis Near-Infrared Fluorescence Imaging
Segment by Application	Cancer Inflammatory Diseases Cardiovascular Disease Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GE Healthcare, Siemens Healthineers (A Subsidiary of Siemens Group), Philips, Canon, Inc., Shimadzu Corporation, Stryker Corporation, Fluoptics, United Imaging Healthcare Co., Ltd., Hitachi, Ltd., Esaote SPA, Neusoft Corporation, Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.), Mitaka Usa, Inc., Curadel, LLC, Impedimed Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Lymphedema Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lymphedema Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lymphedema Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Lymphedema Diagnostics Market growing?

Ans: The Lymphedema Diagnostics Market witnessing a CAGR of 5.4 during the forecast period 2025-2030.

What is the Lymphedema Diagnostics Market size in 2030?

Ans: The Lymphedema Diagnostics Market size in 2030 will be US$ 39 million.

Who are the main players in the Lymphedema Diagnostics Market report?

Ans: The main players in the Lymphedema Diagnostics Market are GE Healthcare, Siemens Healthineers (A Subsidiary of Siemens Group), Philips, Canon, Inc., Shimadzu Corporation, Stryker Corporation, Fluoptics, United Imaging Healthcare Co., Ltd., Hitachi, Ltd., Esaote SPA, Neusoft Corporation, Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.), Mitaka Usa, Inc., Curadel, LLC, Impedimed Limited

What are the Application segmentation covered in the Lymphedema Diagnostics Market report?

Ans: The Applications covered in the Lymphedema Diagnostics Market report are Cancer, Inflammatory Diseases, Cardiovascular Disease, Other

What are the Type segmentation covered in the Lymphedema Diagnostics Market report?

Ans: The Types covered in the Lymphedema Diagnostics Market report are Lymphoscintigraphy, Magnetic Resonance Imaging, Ultrasound Imaging, Computed Tomography, X-Ray Lymphography, Bioimpedance Analysis, Near-Infrared Fluorescence Imaging

Recommended Reports

Diagnostics Technology

Cancer Diagnostics

Lymphatic & Edema

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lymphedema Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Lymphoscintigraphy

1.2.3 Magnetic Resonance Imaging

1.2.4 Ultrasound Imaging

1.2.5 Computed Tomography

1.2.6 X-Ray Lymphography

1.2.7 Bioimpedance Analysis

1.2.8 Near-Infrared Fluorescence Imaging

1.3 Market by Application

1.3.1 Global Lymphedema Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Cancer

1.3.3 Inflammatory Diseases

1.3.4 Cardiovascular Disease

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lymphedema Diagnostics Market Perspective (2019-2030)

2.2 Global Lymphedema Diagnostics Growth Trends by Region

2.2.1 Lymphedema Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Lymphedema Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Lymphedema Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Lymphedema Diagnostics Market Dynamics

2.3.1 Lymphedema Diagnostics Industry Trends

2.3.2 Lymphedema Diagnostics Market Drivers

2.3.3 Lymphedema Diagnostics Market Challenges

2.3.4 Lymphedema Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Lymphedema Diagnostics by Players

3.1.1 Global Lymphedema Diagnostics Revenue by Players (2019-2024)

3.1.2 Global Lymphedema Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Lymphedema Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Lymphedema Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Lymphedema Diagnostics Market Concentration Ratio

3.4.1 Global Lymphedema Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lymphedema Diagnostics Revenue in 2023

3.5 Global Key Players of Lymphedema Diagnostics Head office and Area Served

3.6 Global Key Players of Lymphedema Diagnostics, Product and Application

3.7 Global Key Players of Lymphedema Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Lymphedema Diagnostics Breakdown Data by Type

4.1 Global Lymphedema Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Lymphedema Diagnostics Forecasted Market Size by Type (2025-2030)

5 Lymphedema Diagnostics Breakdown Data by Application

5.1 Global Lymphedema Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Lymphedema Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Lymphedema Diagnostics Market Size (2019-2030)

6.2 North America Lymphedema Diagnostics Market Size by Type

6.2.1 North America Lymphedema Diagnostics Market Size by Type (2019-2024)

6.2.2 North America Lymphedema Diagnostics Market Size by Type (2025-2030)

6.2.3 North America Lymphedema Diagnostics Market Share by Type (2019-2030)

6.3 North America Lymphedema Diagnostics Market Size by Application

6.3.1 North America Lymphedema Diagnostics Market Size by Application (2019-2024)

6.3.2 North America Lymphedema Diagnostics Market Size by Application (2025-2030)

6.3.3 North America Lymphedema Diagnostics Market Share by Application (2019-2030)

6.4 North America Lymphedema Diagnostics Market Size by Country

6.4.1 North America Lymphedema Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Lymphedema Diagnostics Market Size by Country (2019-2024)

6.4.3 North America Lymphedema Diagnostics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Lymphedema Diagnostics Market Size (2019-2030)

7.2 Europe Lymphedema Diagnostics Market Size by Type

7.2.1 Europe Lymphedema Diagnostics Market Size by Type (2019-2024)

7.2.2 Europe Lymphedema Diagnostics Market Size by Type (2025-2030)

7.2.3 Europe Lymphedema Diagnostics Market Share by Type (2019-2030)

7.3 Europe Lymphedema Diagnostics Market Size by Application

7.3.1 Europe Lymphedema Diagnostics Market Size by Application (2019-2024)

7.3.2 Europe Lymphedema Diagnostics Market Size by Application (2025-2030)

7.3.3 Europe Lymphedema Diagnostics Market Share by Application (2019-2030)

7.4 Europe Lymphedema Diagnostics Market Size by Country

7.4.1 Europe Lymphedema Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Lymphedema Diagnostics Market Size by Country (2019-2024)

7.4.3 Europe Lymphedema Diagnostics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Lymphedema Diagnostics Market Size (2019-2030)

8.2 China Lymphedema Diagnostics Market Size by Type

8.2.1 China Lymphedema Diagnostics Market Size by Type (2019-2024)

8.2.2 China Lymphedema Diagnostics Market Size by Type (2025-2030)

8.2.3 China Lymphedema Diagnostics Market Share by Type (2019-2030)

8.3 China Lymphedema Diagnostics Market Size by Application

8.3.1 China Lymphedema Diagnostics Market Size by Application (2019-2024)

8.3.2 China Lymphedema Diagnostics Market Size by Application (2025-2030)

8.3.3 China Lymphedema Diagnostics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Lymphedema Diagnostics Market Size (2019-2030)

9.2 Asia Lymphedema Diagnostics Market Size by Type

9.2.1 Asia Lymphedema Diagnostics Market Size by Type (2019-2024)

9.2.2 Asia Lymphedema Diagnostics Market Size by Type (2025-2030)

9.2.3 Asia Lymphedema Diagnostics Market Share by Type (2019-2030)

9.3 Asia Lymphedema Diagnostics Market Size by Application

9.3.1 Asia Lymphedema Diagnostics Market Size by Application (2019-2024)

9.3.2 Asia Lymphedema Diagnostics Market Size by Application (2025-2030)

9.3.3 Asia Lymphedema Diagnostics Market Share by Application (2019-2030)

9.4 Asia Lymphedema Diagnostics Market Size by Region

9.4.1 Asia Lymphedema Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Lymphedema Diagnostics Market Size by Region (2019-2024)

9.4.3 Asia Lymphedema Diagnostics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Lymphedema Diagnostics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Lymphedema Diagnostics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 GE Healthcare

11.1.1 GE Healthcare Company Details

11.1.2 GE Healthcare Business Overview

11.1.3 GE Healthcare Lymphedema Diagnostics Introduction

11.1.4 GE Healthcare Revenue in Lymphedema Diagnostics Business (2019-2024)

11.1.5 GE Healthcare Recent Developments

11.2 Siemens Healthineers (A Subsidiary of Siemens Group)

11.2.1 Siemens Healthineers (A Subsidiary of Siemens Group) Company Details

11.2.2 Siemens Healthineers (A Subsidiary of Siemens Group) Business Overview

11.2.3 Siemens Healthineers (A Subsidiary of Siemens Group) Lymphedema Diagnostics Introduction

11.2.4 Siemens Healthineers (A Subsidiary of Siemens Group) Revenue in Lymphedema Diagnostics Business (2019-2024)

11.2.5 Siemens Healthineers (A Subsidiary of Siemens Group) Recent Developments

11.3 Philips

11.3.1 Philips Company Details

11.3.2 Philips Business Overview

11.3.3 Philips Lymphedema Diagnostics Introduction

11.3.4 Philips Revenue in Lymphedema Diagnostics Business (2019-2024)

11.3.5 Philips Recent Developments

11.4 Canon, Inc.

11.4.1 Canon, Inc. Company Details

11.4.2 Canon, Inc. Business Overview

11.4.3 Canon, Inc. Lymphedema Diagnostics Introduction

11.4.4 Canon, Inc. Revenue in Lymphedema Diagnostics Business (2019-2024)

11.4.5 Canon, Inc. Recent Developments

11.5 Shimadzu Corporation

11.5.1 Shimadzu Corporation Company Details

11.5.2 Shimadzu Corporation Business Overview

11.5.3 Shimadzu Corporation Lymphedema Diagnostics Introduction

11.5.4 Shimadzu Corporation Revenue in Lymphedema Diagnostics Business (2019-2024)

11.5.5 Shimadzu Corporation Recent Developments

11.6 Stryker Corporation

11.6.1 Stryker Corporation Company Details

11.6.2 Stryker Corporation Business Overview

11.6.3 Stryker Corporation Lymphedema Diagnostics Introduction

11.6.4 Stryker Corporation Revenue in Lymphedema Diagnostics Business (2019-2024)

11.6.5 Stryker Corporation Recent Developments

11.7 Fluoptics

11.7.1 Fluoptics Company Details

11.7.2 Fluoptics Business Overview

11.7.3 Fluoptics Lymphedema Diagnostics Introduction

11.7.4 Fluoptics Revenue in Lymphedema Diagnostics Business (2019-2024)

11.7.5 Fluoptics Recent Developments

11.8 United Imaging Healthcare Co., Ltd.

11.8.1 United Imaging Healthcare Co., Ltd. Company Details

11.8.2 United Imaging Healthcare Co., Ltd. Business Overview

11.8.3 United Imaging Healthcare Co., Ltd. Lymphedema Diagnostics Introduction

11.8.4 United Imaging Healthcare Co., Ltd. Revenue in Lymphedema Diagnostics Business (2019-2024)

11.8.5 United Imaging Healthcare Co., Ltd. Recent Developments

11.9 Hitachi, Ltd.

11.9.1 Hitachi, Ltd. Company Details

11.9.2 Hitachi, Ltd. Business Overview

11.9.3 Hitachi, Ltd. Lymphedema Diagnostics Introduction

11.9.4 Hitachi, Ltd. Revenue in Lymphedema Diagnostics Business (2019-2024)

11.9.5 Hitachi, Ltd. Recent Developments

11.10 Esaote SPA

11.10.1 Esaote SPA Company Details

11.10.2 Esaote SPA Business Overview

11.10.3 Esaote SPA Lymphedema Diagnostics Introduction

11.10.4 Esaote SPA Revenue in Lymphedema Diagnostics Business (2019-2024)

11.10.5 Esaote SPA Recent Developments

11.11 Neusoft Corporation

11.11.1 Neusoft Corporation Company Details

11.11.2 Neusoft Corporation Business Overview

11.11.3 Neusoft Corporation Lymphedema Diagnostics Introduction

11.11.4 Neusoft Corporation Revenue in Lymphedema Diagnostics Business (2019-2024)

11.11.5 Neusoft Corporation Recent Developments

11.12 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.)

11.12.1 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Company Details

11.12.2 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Business Overview

11.12.3 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Lymphedema Diagnostics Introduction

11.12.4 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Revenue in Lymphedema Diagnostics Business (2019-2024)

11.12.5 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Recent Developments

11.13 Mitaka Usa, Inc.

11.13.1 Mitaka Usa, Inc. Company Details

11.13.2 Mitaka Usa, Inc. Business Overview

11.13.3 Mitaka Usa, Inc. Lymphedema Diagnostics Introduction

11.13.4 Mitaka Usa, Inc. Revenue in Lymphedema Diagnostics Business (2019-2024)

11.13.5 Mitaka Usa, Inc. Recent Developments

11.14 Curadel, LLC

11.14.1 Curadel, LLC Company Details

11.14.2 Curadel, LLC Business Overview

11.14.3 Curadel, LLC Lymphedema Diagnostics Introduction

11.14.4 Curadel, LLC Revenue in Lymphedema Diagnostics Business (2019-2024)

11.14.5 Curadel, LLC Recent Developments

11.15 Impedimed Limited

11.15.1 Impedimed Limited Company Details

11.15.2 Impedimed Limited Business Overview

11.15.3 Impedimed Limited Lymphedema Diagnostics Introduction

11.15.4 Impedimed Limited Revenue in Lymphedema Diagnostics Business (2019-2024)

11.15.5 Impedimed Limited Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

GE Healthcare

Siemens Healthineers (A Subsidiary of Siemens Group)

Philips

Canon Inc

Shimadzu Corporation

Stryker Corporation

FLUOPTICS

United Imaging Healthcare Co., Ltd.

Hitachi

Esaote SpA

Neusoft Corporation

Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.)

Mitaka USA, Inc

Curadel, LLC

ImpediMed

List of Tables

Table 1. Global Lymphedema Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Lymphoscintigraphy

Table 3. Key Players of Magnetic Resonance Imaging

Table 4. Key Players of Ultrasound Imaging

Table 5. Key Players of Computed Tomography

Table 6. Key Players of X-Ray Lymphography

Table 7. Key Players of Bioimpedance Analysis

Table 8. Key Players of Near-Infrared Fluorescence Imaging

Table 9. Global Lymphedema Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 10. Global Lymphedema Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Lymphedema Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 12. Global Lymphedema Diagnostics Market Share by Region (2019-2024)

Table 13. Global Lymphedema Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 14. Global Lymphedema Diagnostics Market Share by Region (2025-2030)

Table 15. Lymphedema Diagnostics Market Trends

Table 16. Lymphedema Diagnostics Market Drivers

Table 17. Lymphedema Diagnostics Market Challenges

Table 18. Lymphedema Diagnostics Market Restraints

Table 19. Global Lymphedema Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 20. Global Lymphedema Diagnostics Revenue Share by Players (2019-2024)

Table 21. Global Top Lymphedema Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lymphedema Diagnostics as of 2023)

Table 22. Global Lymphedema Diagnostics Industry Ranking 2022 VS 2023 VS 2024

Table 23. Global 5 Largest Players Market Share by Lymphedema Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 24. Global Key Players of Lymphedema Diagnostics, Headquarters and Area Served

Table 25. Global Key Players of Lymphedema Diagnostics, Product and Application

Table 26. Global Key Players of Lymphedema Diagnostics, Product and Application

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Lymphedema Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 29. Global Lymphedema Diagnostics Revenue Market Share by Type (2019-2024)

Table 30. Global Lymphedema Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 31. Global Lymphedema Diagnostics Revenue Market Share by Type (2025-2030)

Table 32. Global Lymphedema Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 33. Global Lymphedema Diagnostics Revenue Share by Application (2019-2024)

Table 34. Global Lymphedema Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 35. Global Lymphedema Diagnostics Revenue Share by Application (2025-2030)

Table 36. North America Lymphedema Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 37. North America Lymphedema Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 38. North America Lymphedema Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 39. North America Lymphedema Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 40. North America Lymphedema Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. North America Lymphedema Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 42. North America Lymphedema Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 43. Europe Lymphedema Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 44. Europe Lymphedema Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 45. Europe Lymphedema Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 46. Europe Lymphedema Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 47. Europe Lymphedema Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Europe Lymphedema Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 49. Europe Lymphedema Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 50. China Lymphedema Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 51. China Lymphedema Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 52. China Lymphedema Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 53. China Lymphedema Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Lymphedema Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 55. Asia Lymphedema Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 56. Asia Lymphedema Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 57. Asia Lymphedema Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 58. Asia Lymphedema Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 59. Asia Lymphedema Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 60. Asia Lymphedema Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Lymphedema Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 66. Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 67. Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 68. GE Healthcare Company Details

Table 69. GE Healthcare Business Overview

Table 70. GE Healthcare Lymphedema Diagnostics Product

Table 71. GE Healthcare Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 72. GE Healthcare Recent Developments

Table 73. Siemens Healthineers (A Subsidiary of Siemens Group) Company Details

Table 74. Siemens Healthineers (A Subsidiary of Siemens Group) Business Overview

Table 75. Siemens Healthineers (A Subsidiary of Siemens Group) Lymphedema Diagnostics Product

Table 76. Siemens Healthineers (A Subsidiary of Siemens Group) Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 77. Siemens Healthineers (A Subsidiary of Siemens Group) Recent Developments

Table 78. Philips Company Details

Table 79. Philips Business Overview

Table 80. Philips Lymphedema Diagnostics Product

Table 81. Philips Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 82. Philips Recent Developments

Table 83. Canon, Inc. Company Details

Table 84. Canon, Inc. Business Overview

Table 85. Canon, Inc. Lymphedema Diagnostics Product

Table 86. Canon, Inc. Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 87. Canon, Inc. Recent Developments

Table 88. Shimadzu Corporation Company Details

Table 89. Shimadzu Corporation Business Overview

Table 90. Shimadzu Corporation Lymphedema Diagnostics Product

Table 91. Shimadzu Corporation Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 92. Shimadzu Corporation Recent Developments

Table 93. Stryker Corporation Company Details

Table 94. Stryker Corporation Business Overview

Table 95. Stryker Corporation Lymphedema Diagnostics Product

Table 96. Stryker Corporation Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 97. Stryker Corporation Recent Developments

Table 98. Fluoptics Company Details

Table 99. Fluoptics Business Overview

Table 100. Fluoptics Lymphedema Diagnostics Product

Table 101. Fluoptics Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 102. Fluoptics Recent Developments

Table 103. United Imaging Healthcare Co., Ltd. Company Details

Table 104. United Imaging Healthcare Co., Ltd. Business Overview

Table 105. United Imaging Healthcare Co., Ltd. Lymphedema Diagnostics Product

Table 106. United Imaging Healthcare Co., Ltd. Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 107. United Imaging Healthcare Co., Ltd. Recent Developments

Table 108. Hitachi, Ltd. Company Details

Table 109. Hitachi, Ltd. Business Overview

Table 110. Hitachi, Ltd. Lymphedema Diagnostics Product

Table 111. Hitachi, Ltd. Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 112. Hitachi, Ltd. Recent Developments

Table 113. Esaote SPA Company Details

Table 114. Esaote SPA Business Overview

Table 115. Esaote SPA Lymphedema Diagnostics Product

Table 116. Esaote SPA Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 117. Esaote SPA Recent Developments

Table 118. Neusoft Corporation Company Details

Table 119. Neusoft Corporation Business Overview

Table 120. Neusoft Corporation Lymphedema Diagnostics Product

Table 121. Neusoft Corporation Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 122. Neusoft Corporation Recent Developments

Table 123. Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Company Details

Table 124. Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Business Overview

Table 125. Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Lymphedema Diagnostics Product

Table 126. Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 127. Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Recent Developments

Table 128. Mitaka Usa, Inc. Company Details

Table 129. Mitaka Usa, Inc. Business Overview

Table 130. Mitaka Usa, Inc. Lymphedema Diagnostics Product

Table 131. Mitaka Usa, Inc. Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 132. Mitaka Usa, Inc. Recent Developments

Table 133. Curadel, LLC Company Details

Table 134. Curadel, LLC Business Overview

Table 135. Curadel, LLC Lymphedema Diagnostics Product

Table 136. Curadel, LLC Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 137. Curadel, LLC Recent Developments

Table 138. Impedimed Limited Company Details

Table 139. Impedimed Limited Business Overview

Table 140. Impedimed Limited Lymphedema Diagnostics Product

Table 141. Impedimed Limited Revenue in Lymphedema Diagnostics Business (2019-2024) & (US$ Million)

Table 142. Impedimed Limited Recent Developments

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Lymphedema Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Lymphedema Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Lymphoscintigraphy Features

Figure 4. Magnetic Resonance Imaging Features

Figure 5. Ultrasound Imaging Features

Figure 6. Computed Tomography Features

Figure 7. X-Ray Lymphography Features

Figure 8. Bioimpedance Analysis Features

Figure 9. Near-Infrared Fluorescence Imaging Features

Figure 10. Global Lymphedema Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 11. Global Lymphedema Diagnostics Market Share by Application: 2023 VS 2030

Figure 12. Cancer Case Studies

Figure 13. Inflammatory Diseases Case Studies

Figure 14. Cardiovascular Disease Case Studies

Figure 15. Other Case Studies

Figure 16. Lymphedema Diagnostics Report Years Considered

Figure 17. Global Lymphedema Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 18. Global Lymphedema Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Lymphedema Diagnostics Market Share by Region: 2023 VS 2030

Figure 20. Global Lymphedema Diagnostics Market Share by Players in 2023

Figure 21. Global Top Lymphedema Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lymphedema Diagnostics as of 2023)

Figure 22. The Top 10 and 5 Players Market Share by Lymphedema Diagnostics Revenue in 2023

Figure 23. North America Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. North America Lymphedema Diagnostics Market Share by Type (2019-2030)

Figure 25. North America Lymphedema Diagnostics Market Share by Application (2019-2030)

Figure 26. North America Lymphedema Diagnostics Market Share by Country (2019-2030)

Figure 27. United States Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Canada Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Lymphedema Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 30. Europe Lymphedema Diagnostics Market Share by Type (2019-2030)

Figure 31. Europe Lymphedema Diagnostics Market Share by Application (2019-2030)

Figure 32. Europe Lymphedema Diagnostics Market Share by Country (2019-2030)

Figure 33. Germany Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. France Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. U.K. Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Italy Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Russia Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Nordic Countries Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. China Lymphedema Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 40. China Lymphedema Diagnostics Market Share by Type (2019-2030)

Figure 41. China Lymphedema Diagnostics Market Share by Application (2019-2030)

Figure 42. Asia Lymphedema Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 43. Asia Lymphedema Diagnostics Market Share by Type (2019-2030)

Figure 44. Asia Lymphedema Diagnostics Market Share by Application (2019-2030)

Figure 45. Asia Lymphedema Diagnostics Market Share by Region (2019-2030)

Figure 46. Japan Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. South Korea Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. China Taiwan Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Southeast Asia Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. India Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Australia Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America Lymphedema Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 53. Middle East, Africa, and Latin America Lymphedema Diagnostics Market Share by Type (2019-2030)

Figure 54. Middle East, Africa, and Latin America Lymphedema Diagnostics Market Share by Application (2019-2030)

Figure 55. Middle East, Africa, and Latin America Lymphedema Diagnostics Market Share by Country (2019-2030)

Figure 56. Brazil Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Mexico Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Turkey Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Saudi Arabia Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Israel Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. GCC Countries Lymphedema Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 62. GE Healthcare Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 63. Siemens Healthineers (A Subsidiary of Siemens Group) Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 64. Philips Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 65. Canon, Inc. Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 66. Shimadzu Corporation Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 67. Stryker Corporation Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 68. Fluoptics Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 69. United Imaging Healthcare Co., Ltd. Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 70. Hitachi, Ltd. Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 71. Esaote SPA Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 72. Neusoft Corporation Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 73. Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 74. Mitaka Usa, Inc. Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 75. Curadel, LLC Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 76. Impedimed Limited Revenue Growth Rate in Lymphedema Diagnostics Business (2019-2024)

Figure 77. Bottom-up and Top-down Approaches for This Report

Figure 78. Data Triangulation

Figure 79. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.